Follicle Stimulating Hormone Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4102948
- 100 Pages
- November 2020
- Medical Devices
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Follicle Stimulating Hormone market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Follicle Stimulating Hormone market segmented into
Infertility Treatment
Urinary FSH
Based on the end-use, the global Follicle Stimulating Hormone market classified into
Infertility Treatment
Assisted Reproductive Technology
Based on geography, the global Follicle Stimulating Hormone market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Merck Serono
MSD
IBSA
Ferring
Livzon
Techwell
GenSci
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL FOLLICLE STIMULATING HORMONE INDUSTRY
2.1 Summary about Follicle Stimulating Hormone Industry
2.2 Follicle Stimulating Hormone Market Trends
2.2.1 Follicle Stimulating Hormone Production & Consumption Trends
2.2.2 Follicle Stimulating Hormone Demand Structure Trends
2.3 Follicle Stimulating Hormone Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Recombinant FSH
4.2.2 Urinary FSH
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Infertility Treatment
4.3.2 Assisted Reproductive Technology
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Recombinant FSH
5.2.2 Urinary FSH
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Infertility Treatment
5.3.2 Assisted Reproductive Technology
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Recombinant FSH
6.2.2 Urinary FSH
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Infertility Treatment
6.3.2 Assisted Reproductive Technology
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Recombinant FSH
7.2.2 Urinary FSH
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Infertility Treatment
7.3.2 Assisted Reproductive Technology
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Recombinant FSH
8.2.2 Urinary FSH
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Infertility Treatment
8.3.2 Assisted Reproductive Technology
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Recombinant FSH
9.2.2 Urinary FSH
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Infertility Treatment
9.3.2 Assisted Reproductive Technology
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Merck Serono
10.1.2 MSD
10.1.3 IBSA
10.1.4 Ferring
10.1.5 Livzon
10.1.6 Techwell
10.1.7 GenSci
10.2 Follicle Stimulating Hormone Sales Date of Major Players (2017-2020e)
10.2.1 Merck Serono
10.2.2 MSD
10.2.3 IBSA
10.2.4 Ferring
10.2.5 Livzon
10.2.6 Techwell
10.2.7 GenSci
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.Table Follicle Stimulating Hormone Product Type Overview
2.Table Follicle Stimulating Hormone Product Type Market Share List
3.Table Follicle Stimulating Hormone Product Type of Major Players
4.Table Brief Introduction of Merck Serono
5.Table Brief Introduction of MSD
6.Table Brief Introduction of IBSA
7.Table Brief Introduction of Ferring
8.Table Brief Introduction of Livzon
9.Table Brief Introduction of Techwell
10.Table Brief Introduction of GenSci
11.Table Products & Services of Merck Serono
12.Table Products & Services of MSD
13.Table Products & Services of IBSA
14.Table Products & Services of Ferring
15.Table Products & Services of Livzon
16.Table Products & Services of Techwell
17.Table Products & Services of GenSci
18.Table Market Distribution of Major Players
19.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
20.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
21.Table Global Follicle Stimulating Hormone Market Forecast (Million USD) by Region 2021f-2026f
22.Table Global Follicle Stimulating Hormone Market Forecast (Million USD) Share by Region 2021f-2026f
23.Table Global Follicle Stimulating Hormone Market Forecast (Million USD) by Demand 2021f-2026f
24.Table Global Follicle Stimulating Hormone Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
